Dr. Zach Hall was the first President of the California Institute for Regenerative Medicine (CIRM). CIRM funds stem cell research at research institutions and companies throughout California. The organization was established in 2004 with the passage of Proposition 71, which provided $3 billion in funding. Our grants support research with embryonic, adult and reprogrammed (iPS) stem cells, all with the goal of bringing new medical therapies to the people of California and the world.
Previously, Dr. Hall was Director, National Institute of Neurological Disorders and Stroke, Director of the Zilkha Neurogenetic Institute, and Senior Associate Dean for Academic Development at the Keck School of Medicine of the University of Southern California. Dr. Hall is the author and editor of An Introduction to Molecular Neurobiology, a widely used textbook, and has published more than 100 original papers and reviews in scientific journals.
In our 1/4/2006 interview, Dr. Hall discusses
- Timing for availability of therapies based on stem cell research
- The relationship between therapeutic cloning and reproductive cloning
- CIRM accomplishments in its first year of existence (2005)